Učitavanje...
Efficacy and safety of evocalcet in Japanese peritoneal dialysis patients
BACKGROUND: Secondary hyperparathyroidism (SHPT) is a serious and common complication in patients receiving peritoneal dialysis (PD). Cinacalcet is currently the recommended therapy for SHPT; however, gastrointestinal (GI)-related symptoms can result in low adherence and high discontinuation rates....
Spremljeno u:
| Izdano u: | Clin Exp Nephrol |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Singapore
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6586709/ https://ncbi.nlm.nih.gov/pubmed/30955188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-019-01692-y |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|